Lipella Pharmaceuticals Inc (LIPO): Rasio rega marang pendapatan
Lipella Pharmaceuticals operations are protected by US regulations, which minimizes trade conflict risks. The company is developing oral therapies for genitourinary system pathologies, leveraging patent protection. The implementation of ESG standards and emissions scrubbing optimize laboratory operations. The P/S time series allows for the correlation of revenue market value with debt, while 7.30 shows the current volume of this metric.
Rincian metrik lan analitis perusahaan Lipella (LIPO)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Lipella Pharmaceuticals|LIPO - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Lipella Pharma|LIPO - Utang perusahaan|Rasio utang marang kapitalisasi buku Lipella|LIPO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lipella Pharmaceuticals|Rasio jangkoan perantara lipella.com
- data bathi resik lan rasio valuasi:
LIPO - Bathi resik perusahaan|Bathi forward Lipella Pharmaceuticals|LIPO - Pangali P/E|Pangali mangsa ngarep rega marang bathi Lipella Pharmaceuticals Inc|LIPO - Pangali PEG|Pangali EV/EBITDA Lipella|LIPO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Lipella Pharmaceuticals|LIPO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan lipella.com|LIPO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Lipella Pharmaceuticals
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:lipella.com LIPO
The P/S ratio determines the market value of a business relative to its annual turnover, allowing for an assessment of the premium paid for each unit of revenue. For Lipella Pharmaceuticals (LIPO), which has fully outsourced its production and research to external contractors, this indicator is critically important, as current P/S dynamics reveal a speculative gap between capitalization and actual sales in the absence of in-house capacities.
Perusahaan pesaing
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue KVUE|Verona Pharma PLC - Rasio rega marang pendapatan|Jyong Biotech Corp - Multiplikator P/S|Koefisien rega marang pendapatan Ligand Corp LGND|Amneal Pharmaceuticals (AMRX) - Rasio rega marang pendapatan|Rasio rega marang dodolan PRGO (perrigo.com)|ALVO (Alvotech SA) - Multiplikator P/S|Rega marang dodolan Liquidia Corp LQDA|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|Rasio rega marang pendapatan ANIP (ANI Pharmaceuticals Corp)|Rasio rega marang pendapatan MannKind Corporation MNKD|amphastar.com - Rasio rega marang pendapatan|Pacira BioSciences, Inc. - Multiplikator P/S|SPRY - Multiplikator P/S|TBPH (Theravance) - Kapitalisasi marang pendapatan|Aquestive Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan scPharmaceuticals, Inc.|Tectonic - Rasio rega marang dodolan|Multiplikator P/S TNXP|SXTC (sxtchina.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S EPRX (Eupraxia Pharmaceuticals Inc.)|Multiplikator P/S BioHarvest Sciences Inc BHST|EXOZ - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ORMP (Oramed Pharmaceuticals)|enterabio.com (ENTX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan MindWalk Holdings, Inc.|ABVC (ABVC BioPharma Inc) - Multiplikator P/S|Multiplikator P/S Cumberland Corp|Multiplikator P/S QNTM|Kapitalisasi marang pendapatan fibrogen.com FGEN|Multiplikator P/S TELO (Telomir Pharmaceuticals, Inc.)|Rani Therapeutics Holdings (RANI) - Rega marang dodolan|SNYR: Kapitalisasi marang pendapatan|RLYB - Multiplikator P/S|LEXX (lexariabioscience.com) - Kapitalisasi marang pendapatan|PULM: Kapitalisasi marang volume dodolan|PTHL (Pheton Holdings Limited) - Multiplikator P/S|Aptorum (APM) - Koefisien rega marang pendapatan|Multiplikator P/S LYRA|Kapitalisasi marang pendapatan Impact BioMedical, Inc. IBO|Multiplikator P/S TNFA (TNF Pharmaceuticals, Inc.)|Multiplikator P/S cbdMD Inc. YCBD|PRFX - Rasio rega marang pendapatan|CYTO: Rasio rega marang pendapatan|Optinose (OPTN) - Rasio rega marang pendapatan|PIRS - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Procaps Group S.A.|Rasio rega marang pendapatan PTPI|Multiplikator P/S QLI|Koefisien rega marang pendapatan Acelyrin Inc.|Rasio rega marang pendapatan TFF Pharma TFFP
